{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:48:18Z","timestamp":1794887298257,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["17253"],"award-info":[{"award-number":["17253"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Regional differences in synaptic degeneration may underlie differences in clinical presentation and neuropathological disease progression in Parkinson\u2019s Disease (PD) and Dementia with Lewy bodies (DLB). Here, we mapped and quantified synaptic degeneration in cortical brain regions in PD, PD with dementia (PDD) and DLB, and assessed whether regional differences in synaptic loss are linked to axonal degeneration and neuropathological burden. We included a total of 47 brain donors, 9 PD, 12 PDD, 6 DLB and 20 non-neurological controls. Synaptophysin\n                    <jats:sup>+<\/jats:sup>\n                    and SV2A\n                    <jats:sup>+<\/jats:sup>\n                    puncta were quantified in eight cortical regions using a high throughput microscopy approach. Neurofilament light chain (NfL) immunoreactivity, Lewy body (LB) density, phosphorylated-tau and amyloid-\u03b2 load were also quantified. Group differences in synaptic density, and associations with neuropathological markers and Clinical Dementia Rating (CDR) scores, were investigated using linear mixed models. We found significantly decreased synaptophysin and SV2A densities in the cortex of PD, PDD and DLB cases compared to controls. Specifically, synaptic density was decreased in cortical regions affected at Braak \u03b1-synuclein stage 5 in PD (middle temporal gyrus, anterior cingulate and insula), and was additionally decreased in cortical regions affected at Braak \u03b1-synuclein stage 4 in PDD and DLB compared to controls (entorhinal cortex, parahippocampal gyrus and fusiform gyrus). Synaptic loss associated with higher NfL immunoreactivity and LB density. Global synaptophysin loss associated with longer disease duration and higher CDR scores. Synaptic neurodegeneration occurred in temporal, cingulate and insular cortices in PD, as well as in parahippocampal regions in PDD and DLB. In addition, synaptic loss was linked to axonal damage and severe \u03b1-synuclein burden. These results, together with the association between synaptic loss and disease progression and cognitive impairment, indicate that regional synaptic loss may underlie clinical differences between PD and PDD\/DLB. Our results might provide useful information for the interpretation of synaptic biomarkers in vivo.\n                  <\/jats:p>","DOI":"10.1186\/s40478-023-01711-w","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T09:02:53Z","timestamp":1704272573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson\u2019s disease and dementia with Lewy bodies"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-2862","authenticated-orcid":false,"given":"Irene","family":"Frigerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud M. A.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby T. G. M. M.","family":"Noordermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Podobnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D. J.","family":"van de Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fnagi.2017.00330","volume":"9","author":"A Bellucci","year":"2017","unstructured":"Bellucci A, Antonini A, Pizzi M, Spano P (2017) The end is the beginning: Parkinson\u2019s Disease in the light of brain imaging. Front Aging Neurosci 9:330","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1711_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/nan.12297","volume":"42","author":"A Bellucci","year":"2016","unstructured":"Bellucci A et al (2016) Review: Parkinson\u2019s Disease: from synaptic loss to connectome dysfunction. Neuropathol Appl Neurobiol 42(1):77\u201394","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"1711_CR3","first-page":"1","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W et al (2017) Parkinson Disease. Nat Reviews Disease Primers 3(1):1\u201321","journal-title":"Nat Reviews Disease Primers"},{"issue":"10","key":"1711_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of Dementia in Parkinson\u2019s Disease. Mov Disorders: Official J Mov Disorder Soc 20(10):1255\u20131263","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"1711_CR5","doi-asserted-by":"crossref","unstructured":"Jellinger KA (2022) Morphological basis of Parkinson disease-associated cognitive impairment: an update. J Neural Transm 1\u201323","DOI":"10.1007\/s00702-022-02522-4"},{"key":"1711_CR6","doi-asserted-by":"publisher","first-page":"120077","DOI":"10.1016\/j.jns.2021.120077","volume":"432","author":"CS e Sousa","year":"2022","unstructured":"e Sousa CS, Alarc\u00e3o J, Martins IP, Ferreira JJ (2022) Frequency of Dementia in Parkinson\u2019s Disease: a systematic review and meta-analysis. J Neurol Sci 432:120077","journal-title":"J Neurol Sci"},{"issue":"12","key":"1711_CR7","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M et al (2007) Clinical diagnostic criteria for Dementia associated with Parkinson\u2019s Disease. Mov Disorders: Official J Mov Disorder Soc 22(12):1689\u20131707","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"issue":"1","key":"1711_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG et al (2017) Diagnosis and management of Dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100","journal-title":"Neurology"},{"issue":"S6","key":"1711_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mds.10557","volume":"18","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disorders: Official J Mov Disorder Soc 18(S6):2\u201312","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"issue":"2","key":"1711_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s Disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1711_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH et al (2019) Lewy pathology in Parkinson\u2019s Disease consists of crowded organelles and lipid membranes. Nat Neurosci 22(7):1099\u20131109","journal-title":"Nat Neurosci"},{"issue":"4","key":"1711_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9 J (2015) The synaptic function of \u03b1-synuclein. J Parkinson\u2019s Disease 5(4):699\u2013713","journal-title":"J Parkinson\u2019s Disease"},{"key":"1711_CR13","doi-asserted-by":"crossref","unstructured":"Longhena F et al (2017) The contribution of \u03b1-synuclein spreading to Parkinson\u2019s disease synaptopathy Neural plasticity, 2017","DOI":"10.1155\/2017\/5012129"},{"issue":"1","key":"1711_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/ijms20010141","volume":"20","author":"F Longhena","year":"2019","unstructured":"Longhena F, Faustini G, Spillantini MG, Bellucci A (2019) Living in promiscuity: the multiple partners of alpha-synuclein at the synapse in physiology and pathology. Int J Mol Sci 20(1):141","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1711_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000107299","volume":"4","author":"S-S Zhan","year":"1993","unstructured":"Zhan S-S, Beyreuther K, Schmitt H (1993) Quantitative Assessment of the Synaptophysin Immuno-Reactivity of the cortical neuropil in various neurodegenerative disorderswith Dementia. Dement Geriatr Cogn Disord 4(2):66\u201374","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"1711_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/brain\/awx352","volume":"141","author":"E Bereczki","year":"2018","unstructured":"Bereczki E et al (2018) Synaptic markers of cognitive decline in neurodegenerative Diseases: a proteomic approach. Brain 141(2):582\u2013595","journal-title":"Brain"},{"issue":"11","key":"1711_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","volume":"12","author":"E Bereczki","year":"2016","unstructured":"Bereczki E et al (2016) Synaptic proteins predict cognitive decline in Alzheimer\u2019s Disease and Lewy body Dementia. Alzheimer\u2019s Dement 12(11):1149\u20131158","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"1711_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-016-0004-y","volume":"3","author":"E Bereczki","year":"2017","unstructured":"Bereczki E et al (2017) Synaptic proteins in CSF relate to Parkinson\u2019s Disease stage markers. Npj Parkinson\u2019s Disease 3(1):1\u20135","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"8","key":"1711_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/biom10081177","volume":"10","author":"M Chatterjee","year":"2020","unstructured":"Chatterjee M et al (2020) Contactin-1 is reduced in cerebrospinal fluid of parkinson\u2019s Disease patients and is present within lewy bodies. Biomolecules 10(8):1177","journal-title":"Biomolecules"},{"issue":"11","key":"1711_CR20","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/mds.28704","volume":"36","author":"S Lerche","year":"2021","unstructured":"Lerche S et al (2021) CSF protein level of neurotransmitter secretion, synaptic plasticity, and autophagy in PD and DLB. Mov Disord 36(11):2595\u20132604","journal-title":"Mov Disord"},{"issue":"2","key":"1711_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/mds.29287","volume":"38","author":"J Nilsson","year":"2023","unstructured":"Nilsson J et al (2023) Cerebrospinal fluid biomarkers of synaptic dysfunction are altered in Parkinson\u2019s Disease and Related disorders. Mov Disord 38(2):267\u2013277","journal-title":"Mov Disord"},{"key":"1711_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ddtec.2017.11.003","volume":"25","author":"J Mercier","year":"2017","unstructured":"Mercier J, Provins L, Valade A (2017) Discovery and development of SV2A PET tracers: potential for imaging synaptic density and clinical applications. Drug Discovery Today: Technologies 25:45\u201352","journal-title":"Drug Discovery Today: Technologies"},{"issue":"3","key":"1711_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.25682","volume":"87","author":"D Matuskey","year":"2020","unstructured":"Matuskey D et al (2020) Synaptic changes in Parkinson Disease assessed with in vivo imaging. Ann Neurol 87(3):329\u2013338","journal-title":"Ann Neurol"},{"issue":"9","key":"1711_CR24","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/mds.28617","volume":"36","author":"KB Andersen","year":"2021","unstructured":"Andersen KB et al (2021) Reduced synaptic density in patients with Lewy Body Dementia: an [11\u00a0C] UCB-J PET imaging study. Mov Disord 36(9):2057\u20132065","journal-title":"Mov Disord"},{"issue":"8","key":"1711_CR25","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/mds.28064","volume":"35","author":"H Wilson","year":"2020","unstructured":"Wilson H et al (2020) Mitochondrial complex 1, sigma 1, and synaptic vesicle 2A in early drug-naive Parkinson\u2019s Disease. Mov Disord 35(8):1416\u20131427","journal-title":"Mov Disord"},{"issue":"10","key":"1711_CR26","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnen\/nlw070","volume":"75","author":"DH Hepp","year":"2016","unstructured":"Hepp DH et al (2016) Distribution and load of amyloid-\u03b2 pathology in Parkinson Disease and Dementia with Lewy bodies. J Neuropathology Experimental Neurol 75(10):936\u2013945","journal-title":"J Neuropathology Experimental Neurol"},{"issue":"1","key":"1711_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ et al (2017) Neuropathological and genetic correlates of survival and Dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16(1):55\u201365","journal-title":"Lancet Neurol"},{"issue":"4","key":"1711_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ et al (2012) Neuropathologic substrates of Parkinson Disease Dementia. Ann Neurol 72(4):587\u2013598","journal-title":"Ann Neurol"},{"issue":"1","key":"1711_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-022-00328-8","volume":"12","author":"I Frigerio","year":"2023","unstructured":"Frigerio I et al (2023) Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson\u2019s Disease Dementia. Translational Neurodegeneration 12(1):3","journal-title":"Translational Neurodegeneration"},{"issue":"1","key":"1711_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ et al (2021) A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun 12(1):1\u201312","journal-title":"Nat Commun"},{"key":"1711_CR31","first-page":"101698","volume-title":"Normal aging brain Collection Amsterdam (NABCA): a comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls","author":"LE Jonkman","year":"2019","unstructured":"Jonkman LE et al (2019) Normal aging brain Collection Amsterdam (NABCA): a comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls, vol 22. Clinical, NeuroImage, p 101698"},{"issue":"12","key":"1711_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s Disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"key":"1711_CR33","first-page":"1588","volume":"41","author":"JC Morris","year":"1991","unstructured":"Morris JC (1991) The clinical Dementia rating (cdr): current version and. Young 41:1588\u20131592","journal-title":"Young"},{"issue":"3","key":"1711_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I et al (2009) Assessment of \u03b2-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117(3):309\u2013320","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1711_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I et al (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s Disease: a study of the BrainNet Europe Consortium. Brain Pathol 18(4):484\u2013496","journal-title":"Brain Pathol"},{"issue":"6","key":"1711_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I et al (2009) Staging\/typing of Lewy body related \u03b1-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117(6):635\u2013652","journal-title":"Acta Neuropathol"},{"key":"1711_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnana.2013.00020","volume":"7","author":"J Morales","year":"2013","unstructured":"Morales J et al (2013) Characterization and extraction of the synaptic apposition surface for synaptic geometry analysis. Front Neuroanat 7:20","journal-title":"Front Neuroanat"},{"issue":"1","key":"1711_CR38","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7(1):16878","journal-title":"Sci Rep"},{"issue":"5","key":"1711_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/bpa.12442","volume":"27","author":"T Arendt","year":"2017","unstructured":"Arendt T et al (2017) Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution? Brain Pathol 27(5):603\u2013611","journal-title":"Brain Pathol"},{"issue":"4","key":"1711_CR40","doi-asserted-by":"publisher","first-page":"fcab281","DOI":"10.1093\/braincomms\/fcab281","volume":"3","author":"I Frigerio","year":"2021","unstructured":"Frigerio I et al (2021) Amyloid-\u03b2, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer\u2019s Disease. Brain Commun 3(4):fcab281","journal-title":"Brain Commun"},{"issue":"1","key":"1711_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ et al (2012) National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s Disease: a practical approach. Acta Neuropathol 123(1):1\u201311","journal-title":"Acta Neuropathol"},{"issue":"12","key":"1711_CR42","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791\u20131800","journal-title":"Neurology"},{"issue":"4","key":"1711_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H et al (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389\u2013404","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1711_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR et al (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61(3):282\u2013293","journal-title":"J Neuropathol Exp Neurol"},{"issue":"40","key":"1711_CR45","doi-asserted-by":"publisher","first-page":"24534","DOI":"10.1016\/S0021-9258(17)31422-9","volume":"269","author":"N Calakos","year":"1994","unstructured":"Calakos N, Scheller RH (1994) Vesicle-associated membrane protein and synaptophysin are associated on the synaptic vesicle. J Biol Chem 269(40):24534\u201324537","journal-title":"J Biol Chem"},{"issue":"9","key":"1711_CR46","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1021\/acschemneuro.9b00351","volume":"10","author":"KA Stout","year":"2019","unstructured":"Stout KA, Dunn AR, Hoffman C, Miller GW (2019) The synaptic vesicle glycoprotein 2: structure, function, and Disease relevance. ACS Chem Neurosci 10(9):3927\u20133938","journal-title":"ACS Chem Neurosci"},{"key":"1711_CR47","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.neuroimage.2017.08.035","volume":"197","author":"N Palomero-Gallagher","year":"2019","unstructured":"Palomero-Gallagher N, Zilles K (2019) Cortical layers: Cyto-, myelo-, receptor-and synaptic architecture in human cortical areas. NeuroImage 197:716\u2013741","journal-title":"NeuroImage"},{"key":"1711_CR48","doi-asserted-by":"crossref","unstructured":"Mecca AP et al (2020) Association between cerebrospinal fluid biomarkers of neurodegeneration and PET measurements of synaptic density in Alzheimer\u2019s Disease: Neuroimaging\/multi-modal comparisons, vol 16. Alzheimer\u2019s & Dementia, p e044211","DOI":"10.1002\/alz.044211"},{"issue":"1","key":"1711_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM et al (2010) Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65(1):66\u201379","journal-title":"Neuron"},{"issue":"1","key":"1711_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/NEN.0b013e31827c5710","volume":"72","author":"EB Mukaetova-Ladinska","year":"2013","unstructured":"Mukaetova-Ladinska EB et al (2013) Synaptic proteins and choline acetyltransferase loss in visual cortex in Dementia with Lewy bodies. J Neuropathology Experimental Neurol 72(1):53\u201360","journal-title":"J Neuropathology Experimental Neurol"},{"key":"1711_CR51","doi-asserted-by":"crossref","unstructured":"Koffie RM et al (2009) Oligomeric amyloid \u03b2 associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques Proceedings of the National Academy of Sciences, 106(10): p.\u00a04012\u20134017","DOI":"10.1073\/pnas.0811698106"},{"issue":"2","key":"1711_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cne.21176","volume":"500","author":"H Dong","year":"2007","unstructured":"Dong H, Martin MV, Chambers S, Csernansky JG (2007) Spatial relationship between synapse loss and \u03b2-amyloid deposition in Tg2576 mice. J Comp Neurol 500(2):311\u2013321","journal-title":"J Comp Neurol"},{"key":"1711_CR53","first-page":"1","volume":"Preprint","author":"R Mabrouk","year":"2022","unstructured":"Mabrouk R, Gotkiewicz M, Rauramaa T, Tanila H (2022) DAPI (4\u2019, 6-diamidino-2-phenylindole) stains Compact amyloid plaques. J Alzheimers Dis Preprint:1\u20137","journal-title":"J Alzheimers Dis"},{"key":"1711_CR54","doi-asserted-by":"crossref","unstructured":"O\u2019Dell RS et al (2021) Association of A\u03b2 deposition and regional synaptic density in early Alzheimer\u2019s disease: A PET imaging study with [11\u00a0C], vol 13. UCB-J. Alzheimer\u2019s Research & Therapy, pp 1\u201312","DOI":"10.1186\/s13195-020-00742-y"},{"issue":"7","key":"1711_CR55","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.neurobiolaging.2007.10.001","volume":"30","author":"E Head","year":"2009","unstructured":"Head E et al (2009) Synaptic proteins, neuropathology and cognitive status in the oldest-old. Neurobiol Aging 30(7):1125\u20131134","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1711_CR56","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s Disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 30(4):572\u2013580","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"12","key":"1711_CR57","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/archneurol.2011.725","volume":"68","author":"D Weintraub","year":"2011","unstructured":"Weintraub D et al (2011) Neurodegeneration across stages of cognitive decline in Parkinson Disease. Arch Neurol 68(12):1562\u20131568","journal-title":"Arch Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01711-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01711-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01711-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T09:11:01Z","timestamp":1704273061000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01711-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01711-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.07.570569","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"2 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All donors signed an informed consent for brain donation and the use of material and clinical information for research purposes. The procedures for brain tissue collection of NBB and NABCA have been approved by the Medical Ethical Committee of Amsterdam UMC, Vrije Universiteit Amsterdam.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Supporting data include supplementary tables, supplementary figures, and supplementary results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of supporting data"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}